About us
Celtic Biotech is developing novel candidate therapies for the treatment of solid cancers and pain in humans. Derived from specialised receptor binding proteins found in snake venom, these product candidates have the potential to increase survival, improve quality-of-life and reduce treatment costs for cancer patients. Celtic Biotech is focusing its research on solid tumours, including non-small-cell lung cancer (NSCLC), as its initial targets. The Company's lead candidate, CB24 (Crotoxin), has been observed to be highly toxic to various tumour cell lines in pre-clinical and early clinical studies.
- Website
-
https://www.celticbiotech.com
External link for Celtic Biotech Ltd
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Dublin
- Type
- Public Company
- Founded
- 2003
- Specialties
- Oncology, Crotoxin, snake venoms, Clinical trials, Analgesia, Cancer Research, and Cancer Treatment
Locations
-
Primary
Get directions
Dublin, IE
Employees at Celtic Biotech Ltd
Updates
-
Fully focused!! EIC Soft Landing USA Two fully focused Celtic Biotech founders at INSEAD in San Francisco yesterday, thanks to a marvelous array of guest speakers, moderators and great pitches, coordinated by the amazing Jillian Manus & EISMEA, and curated so well by Vic (Victoria) Woo of INSEAD. Really looking forward to the rest of this exciting week! 💪 🚀 #EIC #EISMEA #INSEAD #CelticBiotech #BeatingCancerNaturally
-
-
John Reid, Co-founder & COO and Dr. Dorothy Bray, Head of Medical Affairs, attended the inaugural Euro-American Cancer Forum gala dinner at the State Rooms, Dublin Castle last night. Compliments to the All-Ireland Cancer Research Institute for a wonderful event with excellent guests and speakers, and some great networking. #AICRI #ASCO #ECO #CelticBiotech #CancerInnovation #SilverSponsor
-
-
Celtic Biotech is delighted to have made this exclusive list of 15 innovative companies selected to partake in this exciting event & programme in Silicon Valley. Thanks to #EUEIC & #JillianManus for creating this incredible opportunity! #LifeScience #cancerinnovation
We're thrilled to announce that 15 top-tier #EUeic Life & Health Sciences companies are gearing up for an immersive experience in the US market with the EIC USA Soft-landing Programme! ✈️ 🌟 After an intensive pre-departure workshop with top entrepreneur and investor Jillian Manus, these game-changers in health and life sciences are set to embark on their journey to California from 20-22 May 2024. 💡 Supported by the EIC International Trade Fairs and USA Soft-landing (ITF) 3.0 programme and local business partners, they'll dive into Silicon Valley's vibrant ecosystem, armed with cutting-edge solutions and boundless potential. Stay tuned as these innovators prepare to make waves in the US market! 🌊 Meet the companies 👉 bit.ly/3Jq20hb Learn more about the EIC International Trade Fairs and USA Soft-landing programme 👉 https://bit.ly/3OCtIKB #EICSoftlanding
-
-
Like Giuseppe, we have genuine concerns for the manner in which nature and our climate is being degraded. We are developing what we believe to be a wonder drug (first discovered almost 100 years ago) but which has huge potential in oncology, analgesia and also has potent anti-viral properties. It has taken this long to start realising it’s full potential. It is alarming to think how many other potential candidates to treat human illnesses have been lost in that 100 years due to deforestation and lost of wildlife habitat and how much more we will lose over the next 100 if we don’t reverse current trends #nature #cancercure #pain #antivirus
In the News! Celtic Biotech's co-founders, Paul & John Reid, have been interviewed in an article published by the International Business Times about their lead anti-cancer drug, CB-24. The upcoming Phase Ic trials to tackle solid tumors are co-funded by the EU European Innovation Council. Read more about their venom-derived breakthrough here: https://lnkd.in/ewReFKam
Innovating Cancer Treatment: Celtic Biotech's Venom-Derived Breakthroughs
ibtimes.com
-
Our COO & Co-founder John Reid attended this excellent training provided for EU EIC Accelerator beneficiaries in combination with attendance at the hugely popular EIC Research & Innovation Week in Brussels! 👏 #EUEIC #EITHouse #CelticBiotech
-
-
Celtic Biotech recently doubled our colony of Crotalus Durrissus Terrificus at KRZ to scale for our upcoming human trials this year! #KentuckyReptileZoo #cancerresearch #cancerinnovation
Can snakes really save more lives than they take? | Kristen Wiley & James Harrison | TEDxCorbin
https://www.youtube.com/
-
We’re #hiring a Clinical Research Associate at our new UK facility in Nottingham. This is an exciting opportunity to be involved in a cutting edge technology targeting solid tumours in late stage disease. Remote working is possible. Apply today or share this post with your network!
-
In the News! 📰 Co-founders Paul & John Reid were interviewed for an article published today in the International Business Times. Read about our innovative cancer treatment grant-aided by the EU EIC Accelerator health innovation fund. #CelticBiotech #cancerresearch #cancertreatment
In the News again! 🤓📰 The International Business Times published an article today on our work at #CelticBiotech, grant-aided by the EU EIC Accelerator health innovation fund to tackle solid tumours in cancer. #cancerresearch #cancertreatment
Innovating Cancer Treatment: Celtic Biotech's Venom-Derived Breakthroughs
ibtimes.com